| 1 |
Ren J, Fok MR, Zhang Y, Han B, Lin Y. The role of non-steroidal anti-inflammatory drugs as adjuncts to periodontal treatment and in periodontal regeneration. J Transl Med 2023;21:149. [PMID: 36829232 DOI: 10.1186/s12967-023-03990-2] [Reference Citation Analysis]
|
| 2 |
Qi L, Pan X, Chen X, Liu P, Chen M, Zhang Q, Hang X, Tang M, Wen D, Dai L, Chen C, Liu Y, Xu Z. COX-2/PGE2 upregulation contributes to the chromosome 17p-deleted lymphoma. Oncogenesis 2023;12:5. [PMID: 36750552 DOI: 10.1038/s41389-023-00451-9] [Reference Citation Analysis]
|
| 3 |
Thakur M, Tupe RS. Lipoxin and glycation in SREBP signaling: Insight into diabetic cardiomyopathy and associated lipotoxicity. Prostaglandins Other Lipid Mediat 2023;164:106698. [PMID: 36379414 DOI: 10.1016/j.prostaglandins.2022.106698] [Reference Citation Analysis]
|
| 4 |
AlZahrani S, Shinwari Z, Gaafar A, Alaiya A, Al-Kahtani A. Anti-Inflammatory Effect of Specialized Proresolving Lipid Mediators on Mesenchymal Stem Cells: An In Vitro Study. Cells 2022;12. [PMID: 36611915 DOI: 10.3390/cells12010122] [Reference Citation Analysis]
|
| 5 |
Terranova L, Risé P, Gramegna A, Pinna C, Agostoni C, Syrén M, Turolo S, Marchisio P, Amati F, Aliberti S, Sala A, Blasi F. Pro-resolving and pro-inflammatory fatty acid-derived mediators in sputum of stable state bronchiectasis patients.. [DOI: 10.21203/rs.3.rs-2210219/v1] [Reference Citation Analysis]
|
| 6 |
Li YW, Guo Q, Peng QQ, Shen Q, Nie ZK, Ye C, Shi TQ. Recent Development of Advanced Biotechnology in the Oleaginous Fungi for Arachidonic Acid Production. ACS Synth Biol 2022;11:3163-73. [PMID: 36221956 DOI: 10.1021/acssynbio.2c00483] [Reference Citation Analysis]
|
| 7 |
Sufaru I, Teslaru S, Pasarin L, Iovan G, Stoleriu S, Solomon SM. Host Response Modulation Therapy in the Diabetes Mellitus—Periodontitis Conjuncture: A Narrative Review. Pharmaceutics 2022;14:1728. [DOI: 10.3390/pharmaceutics14081728] [Reference Citation Analysis]
|
| 8 |
Marzec JM, Nadadur SS. Inflammation resolution in environmental pulmonary health and morbidity. Toxicol Appl Pharmacol 2022;449:116070. [PMID: 35618031 DOI: 10.1016/j.taap.2022.116070] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 9 |
Frank Lee C, Brown CE, Nielsen AJ, Kim C, Livne-Bar I, Parsons PJ, Boldron C, Autelitano F, Weaver DF, Sivak JM, Reed MA. A Stereocontrolled Total Synthesis of Lipoxin B4 and its Biological Activity as a Pro-Resolving Lipid Mediator of Neuroinflammation. Chemistry 2022;28:e202200360. [PMID: 35491534 DOI: 10.1002/chem.202200360] [Reference Citation Analysis]
|
| 10 |
Thomas C, Wurzer L, Malle E, Ristow M, Madreiter-sokolowski CT. Modulation of Reactive Oxygen Species Homeostasis as a Pleiotropic Effect of Commonly Used Drugs. Front Aging 2022;3. [DOI: 10.3389/fragi.2022.905261] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 11 |
Artru F, McPhail MJW, Triantafyllou E, Trovato FM. Lipids in Liver Failure Syndromes: A Focus on Eicosanoids, Specialized Pro-Resolving Lipid Mediators and Lysophospholipids. Front Immunol 2022;13:867261. [PMID: 35432367 DOI: 10.3389/fimmu.2022.867261] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 12 |
Salazar J, Pirela D, Nava M, Castro A, Angarita L, Parra H, Durán-Agüero S, Rojas-Gómez DM, Galbán N, Añez R, Chacín M, Diaz A, Villasmil N, De Sanctis JB, Bermúdez V. Specialized Proresolving Lipid Mediators: A Potential Therapeutic Target for Atherosclerosis. Int J Mol Sci 2022;23:3133. [PMID: 35328553 DOI: 10.3390/ijms23063133] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 13 |
Yuan J, Lin F, Chen L, Chen W, Pan X, Bai Y, Cai Y, Lu H. Lipoxin A4 regulates M1/M2 macrophage polarization via FPR2-IRF pathway. Inflammopharmacology 2022. [PMID: 35235107 DOI: 10.1007/s10787-022-00942-y] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 14 |
Qiu X, Gao F, Wang K, Zhang Z, Shao C, Xu X. Aspirin in hepatocellular carcinoma: Is it an out-of-date or promising treatment? iLIVER 2022;1:55-64. [DOI: 10.1016/j.iliver.2022.03.003] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 15 |
Czajka P, Przybyłkowski A, Nowak A, Postula M, Wolska M, Mirowska-Guzel D, Czlonkowska A, Eyileten C. Antiplatelet drugs and liver fibrosis. Platelets 2022;33:219-28. [PMID: 33577391 DOI: 10.1080/09537104.2021.1883574] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 16 |
Meriwether D, Jones AE, Ashby JW, Solorzano-Vargas RS, Dorreh N, Noori S, Grijalva V, Ball AB, Semis M, Divakaruni AS, Mack JJ, Herschman HR, Martin MG, Fogelman AM, Reddy ST. Macrophage COX2 Mediates Efferocytosis, Resolution Reprogramming, and Intestinal Epithelial Repair. Cell Mol Gastroenterol Hepatol 2022;13:1095-120. [PMID: 35017061 DOI: 10.1016/j.jcmgh.2022.01.002] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 17 |
Bell JS, Lip GYH, Proietti R. Antiplatelet Drugs in COVID-19: Mechanism of Action and Effect on Prognosis. Contemporary Cardiology 2022. [DOI: 10.1007/978-3-031-15478-2_20] [Reference Citation Analysis]
|
| 18 |
Leonardo Terranova, Patrizia Risé, Andrea Gramegna, Christian Pinna, Carlo Agostoni, Marie-Louise Syrén, Stefano Turolo, Paola Marchisio, Francesco Amati, Stefano Aliberti, Angelo Sala, Francesco Blasi. Pro-resolving and pro-inflammatory fatty acid-derived mediators in sputum of stable state bronchiectasis patients. Respir Res 2022;23:363. [PMID: 36539829 DOI: 10.1186/s12931-022-02301-5] [Reference Citation Analysis]
|
| 19 |
Luo Y, Jin M, Lou L, Yang S, Li C, Li X, Zhou M, Cai C. Role of arachidonic acid lipoxygenase pathway in Asthma. Prostaglandins Other Lipid Mediat 2021;:106609. [PMID: 34954219 DOI: 10.1016/j.prostaglandins.2021.106609] [Reference Citation Analysis]
|
| 20 |
Mainka M, George S, Angioni C, Ebert R, Goebel T, Kampschulte N, Krommes A, Weigert A, Thomas D, Schebb NH, Steinhilber D, Kahnt AS. On the biosynthesis of specialized pro-resolving mediators in human neutrophils and the influence of cell integrity. Biochim Biophys Acta Mol Cell Biol Lipids 2021;:159093. [PMID: 34942381 DOI: 10.1016/j.bbalip.2021.159093] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 21 |
Zhou Y, Khan H, Xiao J, Cheang WS. Effects of Arachidonic Acid Metabolites on Cardiovascular Health and Disease. Int J Mol Sci 2021;22:12029. [PMID: 34769460 DOI: 10.3390/ijms222112029] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 11.0] [Reference Citation Analysis]
|
| 22 |
Liu Y, Wei L, He C, Chen R, Meng L. Lipoxin A4 inhibits ovalbumin-induced airway inflammation and airway remodeling in a mouse model of asthma. Chem Biol Interact 2021;349:109660. [PMID: 34537180 DOI: 10.1016/j.cbi.2021.109660] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 23 |
Hasturk H, Schulte F, Martins M, Sherzai H, Floros C, Cugini M, Chiu CJ, Hardt M, Van Dyke T. Safety and Preliminary Efficacy of a Novel Host-Modulatory Therapy for Reducing Gingival Inflammation. Front Immunol 2021;12:704163. [PMID: 34589083 DOI: 10.3389/fimmu.2021.704163] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
|
| 24 |
Chávez-Castillo M, Ortega Á, Cudris-Torres L, Duran P, Rojas M, Manzano A, Garrido B, Salazar J, Silva A, Rojas-Gomez DM, De Sanctis JB, Bermúdez V. Specialized Pro-Resolving Lipid Mediators: The Future of Chronic Pain Therapy? Int J Mol Sci 2021;22:10370. [PMID: 34638711 DOI: 10.3390/ijms221910370] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 3.5] [Reference Citation Analysis]
|
| 25 |
Huang R, Zhu Z, Wu Q, Bekhit AEA, Wu S, Chen M, Wang J, Ding Y. Whole-plant foods and their macromolecules: untapped approaches to modulate neuroinflammation in Alzheimer's disease. Crit Rev Food Sci Nutr 2021;:1-19. [PMID: 34553662 DOI: 10.1080/10408398.2021.1975093] [Reference Citation Analysis]
|
| 26 |
Sakowicz A, Bralewska M, Pietrucha T, Figueras F, Habrowska-Górczyńska DE, Piastowska-Ciesielska AW, Gach A, Sakowicz B, Rybak-Krzyszkowska M, Huras H, Grzesiak M, Biesiada L. The Preeclamptic Environment Promotes the Activation of Transcription Factor Kappa B by P53/RSK1 Complex in a HTR8/SVneo Trophoblastic Cell Line. Int J Mol Sci 2021;22:10200. [PMID: 34638542 DOI: 10.3390/ijms221910200] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 27 |
Visaga SA, Kalonia H, Verma V, Sinha S, Singh SK, Upadhyay S, Sahdev S, Pansari A, Kumar R, Bandgar M, Karanjule N, Shirumalla RK, Morishita K, Tandon R. Developing selective FPR2 agonists can be a potential approach to treat moderate to severe asthma.. [DOI: 10.1101/2021.09.16.460577] [Reference Citation Analysis]
|
| 28 |
Newman H, Shih YV, Varghese S. Resolution of inflammation in bone regeneration: From understandings to therapeutic applications. Biomaterials 2021;277:121114. [PMID: 34488119 DOI: 10.1016/j.biomaterials.2021.121114] [Cited by in Crossref: 15] [Cited by in F6Publishing: 18] [Article Influence: 7.5] [Reference Citation Analysis]
|
| 29 |
das Dores Pereira R, Rabelo RAN, Leite PG, Cramer A, Botelho AFM, Cruz JS, Régis WCB, Perretti M, Teixeira MM, Machado FS. Role of formyl peptide receptor 2 (FPR2) in modulating immune response and heart inflammation in an experimental model of acute and chronic Chagas disease. Cell Immunol 2021;369:104427. [PMID: 34482259 DOI: 10.1016/j.cellimm.2021.104427] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 30 |
Leuti A, Fava M, Pellegrini N, Maccarrone M. Role of Specialized Pro-Resolving Mediators in Neuropathic Pain. Front Pharmacol 2021;12:717993. [PMID: 34456731 DOI: 10.3389/fphar.2021.717993] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 31 |
Tallima H. Clarification of Arachidonic Acid Metabolic Pathway Intricacies. ACS Omega 2021;6:15559-63. [PMID: 34179599 DOI: 10.1021/acsomega.1c01952] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 32 |
Celejewska-Wójcik N, Kania A, Górka K, Nastałek P, Wójcik K, Gielicz A, Mastalerz L, Sanak M, Sładek K. Eicosanoids and Eosinophilic Inflammation of Airways in Stable COPD. Int J Chron Obstruct Pulmon Dis 2021;16:1415-24. [PMID: 34079245 DOI: 10.2147/COPD.S298678] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 33 |
Zhu X, Peng X, Lin J, Zhang Y, He H, Zhao G. Lipoxin A4 activates ALX/FPR2 to attenuate inflammation in Aspergillus fumigatus keratitis. Int Immunopharmacol 2021;96:107785. [PMID: 34162149 DOI: 10.1016/j.intimp.2021.107785] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 34 |
Mazzocchi A, De Cosmi V, Risé P, Milani GP, Turolo S, Syrén ML, Sala A, Agostoni C. Bioactive Compounds in Edible Oils and Their Role in Oxidative Stress and Inflammation. Front Physiol 2021;12:659551. [PMID: 33995124 DOI: 10.3389/fphys.2021.659551] [Cited by in Crossref: 14] [Cited by in F6Publishing: 18] [Article Influence: 7.0] [Reference Citation Analysis]
|
| 35 |
Tiberi M, Chiurchiù V. Specialized Pro-resolving Lipid Mediators and Glial Cells: Emerging Candidates for Brain Homeostasis and Repair. Front Cell Neurosci 2021;15:673549. [PMID: 33981203 DOI: 10.3389/fncel.2021.673549] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 8.0] [Reference Citation Analysis]
|
| 36 |
Li Y, Wang N, Ma Z, Wang Y, Yuan Y, Zhong Z, Hong Y, Zhao M. Lipoxin A4 protects against paraquat‑induced acute lung injury by inhibiting the TLR4/MyD88‑mediated activation of the NF‑κB and PI3K/AKT pathways. Int J Mol Med 2021;47:86. [PMID: 33760150 DOI: 10.3892/ijmm.2021.4919] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 37 |
Imig JD. Eicosanoid blood vessel regulation in physiological and pathological states. Clin Sci (Lond) 2020;134:2707-27. [PMID: 33095237 DOI: 10.1042/CS20191209] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 7.0] [Reference Citation Analysis]
|
| 38 |
Ansari J, Senchenkova EY, Vital SA, Al-Yafeai Z, Kaur G, Sparkenbaugh EM, Orr AW, Pawlinski R, Hebbel RP, Granger DN, Kubes P, Gavins FNE. Targeting the AnxA1/Fpr2/ALX pathway regulates neutrophil function, promoting thromboinflammation resolution in sickle cell disease. Blood 2021;137:1538-49. [PMID: 33512489 DOI: 10.1182/blood.2020009166] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 9.5] [Reference Citation Analysis]
|
| 39 |
Trippe L, Nava A, Frank A, Nubbemeyer U. Synthesis of Enantiopure 6,11‐Methylene Lipoxin B 4 Methyl Ester. Eur J Org Chem 2021;2021:1156-1167. [DOI: 10.1002/ejoc.202001591] [Reference Citation Analysis]
|
| 40 |
Livshits G, Kalinkovich A. Specialized, pro-resolving mediators as potential therapeutic agents for alleviating fibromyalgia symptomatology. Pain Med 2021:pnab060. [PMID: 33565588 DOI: 10.1093/pm/pnab060] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 41 |
Calder PC. Eicosanoids. Essays Biochem 2020;64:423-41. [PMID: 32808658 DOI: 10.1042/EBC20190083] [Cited by in Crossref: 65] [Cited by in F6Publishing: 71] [Article Influence: 32.5] [Reference Citation Analysis]
|
| 42 |
Lee CH. Role of specialized pro-resolving lipid mediators and their receptors in virus infection: a promising therapeutic strategy for SARS-CoV-2 cytokine storm. Arch Pharm Res 2021;44:84-98. [PMID: 33398691 DOI: 10.1007/s12272-020-01299-y] [Cited by in Crossref: 19] [Cited by in F6Publishing: 13] [Article Influence: 9.5] [Reference Citation Analysis]
|
| 43 |
Liu Z, Fan P, Chen M, Xu Y, Zhao D. miRNAs and Leukotrienes in Respiratory Syncytial Virus Infection. Front Pediatr 2021;9:602195. [PMID: 33996675 DOI: 10.3389/fped.2021.602195] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 44 |
Israel Y, Quintanilla ME, Ezquer F, Morales P, Santapau D, Berríos-Cárcamo P, Ezquer M, Olivares B, Herrera-Marschitz M. Aspirin and N-acetylcysteine co-administration markedly inhibit chronic ethanol intake and block relapse binge drinking: Role of neuroinflammation-oxidative stress self-perpetuation. Addict Biol 2021;26:e12853. [PMID: 31733014 DOI: 10.1111/adb.12853] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 8.0] [Reference Citation Analysis]
|
| 45 |
Hromcik F, Vokurka J, Kyr M, Izakovicova Holla L. Granulation Tissue Enhanced with Aspirin and Omega‐3 PUFAs as a Local Adjunct to the Surgical Treatment of Periodontitis. Eur J Lipid Sci Technol 2021;123:2000259. [DOI: 10.1002/ejlt.202000259] [Reference Citation Analysis]
|
| 46 |
Kang GJ, Kim EJ, Lee CH. Therapeutic Effects of Specialized Pro-Resolving Lipids Mediators on Cardiac Fibrosis via NRF2 Activation. Antioxidants (Basel) 2020;9:E1259. [PMID: 33321955 DOI: 10.3390/antiox9121259] [Cited by in Crossref: 10] [Cited by in F6Publishing: 14] [Article Influence: 3.3] [Reference Citation Analysis]
|
| 47 |
Shanmugalingam R, Wang X, Motum P, Fulcher I, Lee G, Kumar R, Hennessy A, Makris A. The 15-Epilipoxin-A4 Pathway with Prophylactic Aspirin in Preventing Preeclampsia: A Longitudinal Cohort Study. J Clin Endocrinol Metab 2020;105:dgaa642. [PMID: 32930782 DOI: 10.1210/clinem/dgaa642] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 48 |
Morris G, Bortolasci CC, Puri BK, Olive L, Marx W, O'Neil A, Athan E, Carvalho A, Maes M, Walder K, Berk M. Preventing the development of severe COVID-19 by modifying immunothrombosis. Life Sci 2021;264:118617. [PMID: 33096114 DOI: 10.1016/j.lfs.2020.118617] [Cited by in Crossref: 27] [Cited by in F6Publishing: 29] [Article Influence: 9.0] [Reference Citation Analysis]
|
| 49 |
Recchiuti A, Isopi E, Romano M, Mattoscio D. Roles of Specialized Pro-Resolving Lipid Mediators in Autophagy and Inflammation. Int J Mol Sci 2020;21:E6637. [PMID: 32927853 DOI: 10.3390/ijms21186637] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
|
| 50 |
Berríos-Cárcamo P, Quezada M, Quintanilla ME, Morales P, Ezquer M, Herrera-Marschitz M, Israel Y, Ezquer F. Oxidative Stress and Neuroinflammation as a Pivot in Drug Abuse. A Focus on the Therapeutic Potential of Antioxidant and Anti-Inflammatory Agents and Biomolecules. Antioxidants (Basel) 2020;9:E830. [PMID: 32899889 DOI: 10.3390/antiox9090830] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 5.3] [Reference Citation Analysis]
|
| 51 |
Wu H, Wu S, Zhu Y, Cheng J, Ye S, Xi Y, Huang Q, Zhang Y, Bu S. Aspirin restores endothelial function by mitigating 17β-estradiol-induced α-SMA accumulation and autophagy inhibition via Vps15 scaffold regulation of Beclin-1 phosphorylation. Life Sci 2020;259:118383. [PMID: 32896555 DOI: 10.1016/j.lfs.2020.118383] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 52 |
Miyazawa K, Fukunaga H, Tatewaki Y, Takano Y, Yamamoto S, Mutoh T, Taki Y. Alzheimer's Disease and Specialized Pro-Resolving Lipid Mediators: Do MaR1, RvD1, and NPD1 Show Promise for Prevention and Treatment? Int J Mol Sci 2020;21:E5783. [PMID: 32806612 DOI: 10.3390/ijms21165783] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 4.3] [Reference Citation Analysis]
|
| 53 |
Quintanilla ME, Ezquer F, Morales P, Ezquer M, Olivares B, Santapau D, Herrera-Marschitz M, Israel Y. N-Acetylcysteine and Acetylsalicylic Acid Inhibit Alcohol Consumption by Different Mechanisms: Combined Protection. Front Behav Neurosci 2020;14:122. [PMID: 32848653 DOI: 10.3389/fnbeh.2020.00122] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 4.7] [Reference Citation Analysis]
|
| 54 |
Ungaro F, D'Alessio S, Danese S. The Role of Pro-Resolving Lipid Mediators in Colorectal Cancer-Associated Inflammation: Implications for Therapeutic Strategies. Cancers (Basel) 2020;12:E2060. [PMID: 32722560 DOI: 10.3390/cancers12082060] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 55 |
Leuti A, Fazio D, Fava M, Piccoli A, Oddi S, Maccarrone M. Bioactive lipids, inflammation and chronic diseases. Adv Drug Deliv Rev 2020;159:133-69. [PMID: 32628989 DOI: 10.1016/j.addr.2020.06.028] [Cited by in Crossref: 57] [Cited by in F6Publishing: 47] [Article Influence: 19.0] [Reference Citation Analysis]
|
| 56 |
Martinez RM, Fattori V, Saito P, Pinto IC, Rodrigues CCA, Melo CPB, Bussmann AJC, Staurengo-Ferrari L, Bezerra JR, Vignoli JA, Baracat MM, Georgetti SR, Verri WA Jr, Casagrande R. The Lipoxin Receptor/FPR2 Agonist BML-111 Protects Mouse Skin Against Ultraviolet B Radiation. Molecules 2020;25:E2953. [PMID: 32604968 DOI: 10.3390/molecules25122953] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 57 |
Silva AR, Moraes BPT, Gonçalves-de-Albuquerque CF. Mediterranean Diet: Lipids, Inflammation, and Malaria Infection. Int J Mol Sci 2020;21:E4489. [PMID: 32599864 DOI: 10.3390/ijms21124489] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 58 |
Wasserman AH, Venkatesan M, Aguirre A. Bioactive Lipid Signaling in Cardiovascular Disease, Development, and Regeneration. Cells 2020;9:E1391. [PMID: 32503253 DOI: 10.3390/cells9061391] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
|
| 59 |
de Sousa Nogueira Freitas L, da Silva FR, Andrade HA, Guerreiro RC, Paulo FV, de Mello MT, Silva A. Sleep debt induces skeletal muscle injuries in athletes: A promising hypothesis. Med Hypotheses 2020;142:109836. [PMID: 32422497 DOI: 10.1016/j.mehy.2020.109836] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 60 |
Crocetti L, Vergelli C, Guerrini G, Cantini N, Kirpotina LN, Schepetkin IA, Quinn MT, Parisio C, Di Cesare Mannelli L, Ghelardini C, Giovannoni MP. Novel formyl peptide receptor (FPR) agonists with pyridinone and pyrimidindione scaffolds that are potentially useful for the treatment of rheumatoid arthritis. Bioorg Chem 2020;100:103880. [PMID: 32388428 DOI: 10.1016/j.bioorg.2020.103880] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 61 |
Tentolouris A, Eleftheriadou I, Tzeravini E, Tsilingiris D, Paschou SA, Siasos G, Tentolouris N. Endothelium as a Therapeutic Target in Diabetes Mellitus: From Basic Mechanisms to Clinical Practice. Curr Med Chem 2020;27:1089-131. [PMID: 30663560 DOI: 10.2174/0929867326666190119154152] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 5.7] [Reference Citation Analysis]
|
| 62 |
Shoieb SM, El-ghiaty MA, Alqahtani MA, El-kadi AO. Cytochrome P450-derived eicosanoids and inflammation in liver diseases. Prostaglandins & Other Lipid Mediators 2020;147:106400. [DOI: 10.1016/j.prostaglandins.2019.106400] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 63 |
Ebert R, Cumbana R, Lehmann C, Kutzner L, Toewe A, Ferreirós N, Parnham MJ, Schebb NH, Steinhilber D, Kahnt AS. Long-term stimulation of toll-like receptor-2 and -4 upregulates 5-LO and 15-LO-2 expression thereby inducing a lipid mediator shift in human monocyte-derived macrophages. Biochim Biophys Acta Mol Cell Biol Lipids 2020;1865:158702. [PMID: 32222425 DOI: 10.1016/j.bbalip.2020.158702] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 64 |
Michaudel C, Bataille F, Maillet I, Fauconnier L, Colas C, Sokol H, Straube M, Couturier-Maillard A, Dumoutier L, van Snick J, Quesniaux VF, Togbe D, Ryffel B. Ozone-Induced Aryl Hydrocarbon Receptor Activation Controls Lung Inflammation via Interleukin-22 Modulation. Front Immunol 2020;11:144. [PMID: 32161582 DOI: 10.3389/fimmu.2020.00144] [Cited by in Crossref: 20] [Cited by in F6Publishing: 22] [Article Influence: 6.7] [Reference Citation Analysis]
|
| 65 |
Bäck M, Yurdagul A Jr, Tabas I, Öörni K, Kovanen PT. Inflammation and its resolution in atherosclerosis: mediators and therapeutic opportunities. Nat Rev Cardiol 2019;16:389-406. [PMID: 30846875 DOI: 10.1038/s41569-019-0169-2] [Cited by in Crossref: 277] [Cited by in F6Publishing: 365] [Article Influence: 92.3] [Reference Citation Analysis]
|
| 66 |
Kim C, Livne-Bar I, Gronert K, Sivak JM. Fair-Weather Friends: Evidence of Lipoxin Dysregulation in Neurodegeneration. Mol Nutr Food Res 2020;64:e1801076. [PMID: 31797529 DOI: 10.1002/mnfr.201801076] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
|
| 67 |
Fattori V, Zaninelli TH, Rasquel-Oliveira FS, Casagrande R, Verri WA Jr. Specialized pro-resolving lipid mediators: A new class of non-immunosuppressive and non-opioid analgesic drugs. Pharmacol Res 2020;151:104549. [PMID: 31743775 DOI: 10.1016/j.phrs.2019.104549] [Cited by in Crossref: 26] [Cited by in F6Publishing: 27] [Article Influence: 6.5] [Reference Citation Analysis]
|
| 68 |
McCarthy CG, Goulopoulou S, Webb RC. Paying the Toll for Inflammation. Hypertension 2019;73:514-21. [PMID: 30661480 DOI: 10.1161/HYPERTENSIONAHA.118.11782] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 69 |
Habza-Kowalska E, Gawlik-Dziki U, Dziki D. Mechanism of Action and Interactions between Thyroid Peroxidase and Lipoxygenase Inhibitors Derived from Plant Sources. Biomolecules 2019;9:E663. [PMID: 31671724 DOI: 10.3390/biom9110663] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 70 |
Fraga VG, Magalhães CA, Loures CMG, de Souza LC, Guimarães HC, Zauli DAG, Carvalho MDG, Ferreira CN, Caramelli P, de Sousa LP, Gomes KB. Inflammatory and Pro-resolving Mediators in Frontotemporal Dementia and Alzheimer's Disease. Neuroscience 2019;421:123-35. [PMID: 31654714 DOI: 10.1016/j.neuroscience.2019.09.008] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 2.8] [Reference Citation Analysis]
|
| 71 |
Chen Y, Zheng Y, Xin L, Zhong S, Liu A, Lai W, Liu L, Lin C, Liao C, Zeng J, Zhang L. 15-epi-lipoxin A4 inhibits TNF-α-induced tissue factor expression via the PI3K/AKT/ NF-κB axis in human umbilical vein endothelial cells. Biomedicine & Pharmacotherapy 2019;117:109099. [DOI: 10.1016/j.biopha.2019.109099] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
|
| 72 |
Munck Af Rosenschöld M, Johannesson P, Nikitidis A, Tyrchan C, Chang HF, Rönn R, Chapman D, Ullah V, Nikitidis G, Glader P, Käck H, Bonn B, Wågberg F, Björkstrand E, Andersson U, Swedin L, Rohman M, Andreasson T, Bergström EL, Jiang F, Zhou XH, Lundqvist AJ, Malmberg A, Ek M, Gordon E, Pettersen A, Ripa L, Davis AM. Discovery of the Oral Leukotriene C4 Synthase Inhibitor (1S,2S)-2-({5-[(5-Chloro-2,4-difluorophenyl)(2-fluoro-2-methylpropyl)amino]-3-methoxypyrazin-2-yl}carbonyl)cyclopropanecarboxylic Acid (AZD9898) as a New Treatment for Asthma. J Med Chem 2019;62:7769-87. [PMID: 31415176 DOI: 10.1021/acs.jmedchem.9b00555] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 73 |
Cai C, Bian X, Xue M, Liu X, Hu H, Wang J, Zheng SG, Sun B, Wu JL. Eicosanoids metabolized through LOX distinguish asthma-COPD overlap from COPD by metabolomics study. Int J Chron Obstruct Pulmon Dis 2019;14:1769-78. [PMID: 31496676 DOI: 10.2147/COPD.S207023] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 74 |
Ba F, Zhou X, Zhang Y, Wu C, Xu S, Wu L, Li J, Yin Y, Gu X. Lipoxin A4 ameliorates alveolar fluid clearance disturbance in lipopolysaccharide-induced lung injury via aquaporin 5 and MAPK signaling pathway. J Thorac Dis. 2019;11:3599-3608. [PMID: 31559067 DOI: 10.21037/jtd.2019.08.86] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 75 |
Frigerio F, Pasqualini G, Craparotta I, Marchini S, van Vliet EA, Foerch P, Vandenplas C, Leclercq K, Aronica E, Porcu L, Pistorius K, Colas RA, Hansen TV, Perretti M, Kaminski RM, Dalli J, Vezzani A. n-3 Docosapentaenoic acid-derived protectin D1 promotes resolution of neuroinflammation and arrests epileptogenesis. Brain 2018;141:3130-43. [PMID: 30307467 DOI: 10.1093/brain/awy247] [Cited by in Crossref: 14] [Cited by in F6Publishing: 27] [Article Influence: 3.5] [Reference Citation Analysis]
|
| 76 |
Martini AC, Forner S, Trujillo-Estrada L, Baglietto-Vargas D, LaFerla FM. Past to Future: What Animal Models Have Taught Us About Alzheimer's Disease. J Alzheimers Dis 2018;64:S365-78. [PMID: 29504540 DOI: 10.3233/JAD-179917] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 3.5] [Reference Citation Analysis]
|
| 77 |
Recchiuti A, Mattoscio D, Isopi E. Roles, Actions, and Therapeutic Potential of Specialized Pro-resolving Lipid Mediators for the Treatment of Inflammation in Cystic Fibrosis. Front Pharmacol 2019;10:252. [PMID: 31001110 DOI: 10.3389/fphar.2019.00252] [Cited by in Crossref: 29] [Cited by in F6Publishing: 31] [Article Influence: 7.3] [Reference Citation Analysis]
|
| 78 |
de Araújo Pimenta L, de Almeida MES, Bretones ML, Cirillo MC, Curi R, Sampaio SC. Crotoxin promotes macrophage reprogramming towards an antiangiogenic phenotype. Sci Rep 2019;9:4281. [PMID: 30862840 DOI: 10.1038/s41598-019-40903-0] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 79 |
Gan N, Zhang R, Xu X, Wang Y, Qi A, Zhang Y, Wang A. Effects of the ALX/FPR2 receptors of lipoxin A4 on lung injury induced by fat embolism syndrome in rats. Biomed Pharmacother 2019;112:108595. [PMID: 30784911 DOI: 10.1016/j.biopha.2019.01.056] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 80 |
Lotfi R, Rezaiemanesh A, Mortazavi SH, Karaji AG, Salari F. Immunoresolvents in asthma and allergic diseases: Review and update. J Cell Physiol 2019;234:8579-96. [PMID: 30488527 DOI: 10.1002/jcp.27836] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 81 |
Singh NK, Rao GN. Emerging role of 12/15-Lipoxygenase (ALOX15) in human pathologies. Prog Lipid Res 2019;73:28-45. [PMID: 30472260 DOI: 10.1016/j.plipres.2018.11.001] [Cited by in Crossref: 93] [Cited by in F6Publishing: 103] [Article Influence: 18.6] [Reference Citation Analysis]
|
| 82 |
Green AR, Freedman C, Tena J, Tourdot BE, Liu B, Holinstat M, Holman TR. 5 S,15 S-Dihydroperoxyeicosatetraenoic Acid (5,15-diHpETE) as a Lipoxin Intermediate: Reactivity and Kinetics with Human Leukocyte 5-Lipoxygenase, Platelet 12-Lipoxygenase, and Reticulocyte 15-Lipoxygenase-1. Biochemistry 2018;57:6726-34. [PMID: 30407793 DOI: 10.1021/acs.biochem.8b00889] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 3.2] [Reference Citation Analysis]
|
| 83 |
Yang Y, Wang Y, Kong Y, Zhang X, Zhang H, Gang Y, Bai L. The therapeutic effects of lipoxin A4 during treadmill exercise on monosodium iodoacetate-induced osteoarthritis in rats. Molecular Immunology 2018;103:35-45. [DOI: 10.1016/j.molimm.2018.08.027] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 2.4] [Reference Citation Analysis]
|
| 84 |
Sonnweber T, Pizzini A, Nairz M, Weiss G, Tancevski I. Arachidonic Acid Metabolites in Cardiovascular and Metabolic Diseases. Int J Mol Sci 2018;19:E3285. [PMID: 30360467 DOI: 10.3390/ijms19113285] [Cited by in Crossref: 152] [Cited by in F6Publishing: 163] [Article Influence: 30.4] [Reference Citation Analysis]
|
| 85 |
Ji YD, Luo ZL, Chen CX, Li B, Gong J, Wang YX, Chen L, Yao SL, Shang Y. BML-111 suppresses TGF-β1-induced lung fibroblast activation in vitro and decreases experimental pulmonary fibrosis in vivo. Int J Mol Med 2018;42:3083-92. [PMID: 30280199 DOI: 10.3892/ijmm.2018.3914] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 86 |
Philippe R, Urbach V. Specialized Pro-Resolving Lipid Mediators in Cystic Fibrosis. Int J Mol Sci 2018;19:E2865. [PMID: 30241412 DOI: 10.3390/ijms19102865] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 4.2] [Reference Citation Analysis]
|
| 87 |
Shi Z, Ye W, Zhang J, Zhang F, Yu D, Yu H, Chen B, Zhou M, Sun H. LipoxinA4 attenuates acute pancreatitis-associated acute lung injury by regulating AQP-5 and MMP-9 expression, anti-apoptosis and PKC/SSeCKS-mediated F-actin activation. Mol Immunol. 2018;103:78-88. [PMID: 30219663 DOI: 10.1016/j.molimm.2018.09.003] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 2.6] [Reference Citation Analysis]
|
| 88 |
Chen XQ, Wu SH, Luo YY, Li BJ, Li SJ, Lu HY, Jin R, Sun ZY. Lipoxin A4 Attenuates Bronchopulmonary Dysplasia via Upregulation of Let-7c and Downregulation of TGF-β1 Signaling Pathway. Inflammation 2017;40:2094-108. [PMID: 28819748 DOI: 10.1007/s10753-017-0649-7] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 3.6] [Reference Citation Analysis]
|
| 89 |
Colby JK, Jaoude J, Liu F, Shureiqi I. Oxygenated lipid signaling in tumor-associated macrophages—focus on colon cancer. Cancer Metastasis Rev 2018;37:289-315. [DOI: 10.1007/s10555-018-9743-z] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 1.4] [Reference Citation Analysis]
|
| 90 |
Ho CF, Ismail NB, Koh JK, Gunaseelan S, Low YH, Ng YK, Chua JJ, Ong WY. Localisation of Formyl-Peptide Receptor 2 in the Rat Central Nervous System and Its Role in Axonal and Dendritic Outgrowth. Neurochem Res 2018;43:1587-98. [PMID: 29948727 DOI: 10.1007/s11064-018-2573-0] [Cited by in Crossref: 29] [Cited by in F6Publishing: 31] [Article Influence: 5.8] [Reference Citation Analysis]
|
| 91 |
Dalli J, Serhan CN. Identification and structure elucidation of the pro-resolving mediators provides novel leads for resolution pharmacology. Br J Pharmacol 2019;176:1024-37. [PMID: 29679485 DOI: 10.1111/bph.14336] [Cited by in Crossref: 80] [Cited by in F6Publishing: 88] [Article Influence: 16.0] [Reference Citation Analysis]
|
| 92 |
Kroesen VM, Rodríguez-Martínez P, García E, Rosales Y, Díaz J, Martín-Céspedes M, Tapia G, Sarrias MR, Cardona PJ, Vilaplana C. A Beneficial Effect of Low-Dose Aspirin in a Murine Model of Active Tuberculosis. Front Immunol 2018;9:798. [PMID: 29740435 DOI: 10.3389/fimmu.2018.00798] [Cited by in Crossref: 38] [Cited by in F6Publishing: 38] [Article Influence: 7.6] [Reference Citation Analysis]
|
| 93 |
Sorokin AV, Norris PC, English JT, Dey AK, Chaturvedi A, Baumer Y, Silverman J, Playford MP, Serhan CN, Mehta NN. Identification of proresolving and inflammatory lipid mediators in human psoriasis. J Clin Lipidol 2018;12:1047-60. [PMID: 29730187 DOI: 10.1016/j.jacl.2018.03.091] [Cited by in Crossref: 25] [Cited by in F6Publishing: 26] [Article Influence: 5.0] [Reference Citation Analysis]
|
| 94 |
Dzeshka MS, Shantsila A, Lip GY. Effects of Aspirin on Endothelial Function and Hypertension. Curr Hypertens Rep 2016;18:83. [PMID: 27787837 DOI: 10.1007/s11906-016-0688-8] [Cited by in Crossref: 28] [Cited by in F6Publishing: 30] [Article Influence: 5.6] [Reference Citation Analysis]
|
| 95 |
Chistiakov DA, Melnichenko AA, Grechko AV, Myasoedova VA, Orekhov AN. Potential of anti-inflammatory agents for treatment of atherosclerosis. Exp Mol Pathol 2018;104:114-24. [PMID: 29378168 DOI: 10.1016/j.yexmp.2018.01.008] [Cited by in Crossref: 72] [Cited by in F6Publishing: 72] [Article Influence: 14.4] [Reference Citation Analysis]
|
| 96 |
Takiuchi T, Blake EA, Matsuo K, Sood AK, Brasky TM. Aspirin use and endometrial cancer risk and survival. Gynecol Oncol 2018;148:222-32. [PMID: 29132875 DOI: 10.1016/j.ygyno.2017.10.026] [Cited by in Crossref: 27] [Cited by in F6Publishing: 30] [Article Influence: 4.5] [Reference Citation Analysis]
|
| 97 |
Stama ML, Lacivita E, Kirpotina LN, Niso M, Perrone R, Schepetkin IA, Quinn MT, Leopoldo M. Functional N-Formyl Peptide Receptor 2 (FPR2) Antagonists Based on the Ureidopropanamide Scaffold Have Potential To Protect Against Inflammation-Associated Oxidative Stress. ChemMedChem 2017;12:1839-47. [PMID: 28922577 DOI: 10.1002/cmdc.201700429] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
|
| 98 |
Spite M, Serhan CN. Roles of Specialized Proresolving Lipid Mediators in Inflammation Resolution and Tissue Repair. Inflammation - From Molecular and Cellular Mechanisms to the Clinic 2017. [DOI: 10.1002/9783527692156.ch57] [Reference Citation Analysis]
|
| 99 |
Chilton FH, Dutta R, Reynolds LM, Sergeant S, Mathias RA, Seeds MC. Precision Nutrition and Omega-3 Polyunsaturated Fatty Acids: A Case for Personalized Supplementation Approaches for the Prevention and Management of Human Diseases. Nutrients 2017;9:E1165. [PMID: 29068398 DOI: 10.3390/nu9111165] [Cited by in Crossref: 67] [Cited by in F6Publishing: 71] [Article Influence: 11.2] [Reference Citation Analysis]
|
| 100 |
Nguyen TTB, Jin YY, Chung HJ, Hong ST. Pharmabiotics as an Emerging Medication for Metabolic Syndrome and Its Related Diseases. Molecules 2017;22:E1795. [PMID: 29064399 DOI: 10.3390/molecules22101795] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 2.7] [Reference Citation Analysis]
|
| 101 |
Goicoechea M, Sanchez-niño MD, Ortiz A, García de Vinuesa S, Quiroga B, Bernis C, Morales E, Fernández-juarez G, de Sequera P, Verdalles U, Verde E, Luño J. Low dose aspirin increases 15-epi-lipoxin A4 levels in diabetic chronic kidney disease patients. Prostaglandins, Leukotrienes and Essential Fatty Acids 2017;125:8-13. [DOI: 10.1016/j.plefa.2017.08.009] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 102 |
Stama ML, Ślusarczyk J, Lacivita E, Kirpotina LN, Schepetkin IA, Chamera K, Riganti C, Perrone R, Quinn MT, Basta-Kaim A, Leopoldo M. Novel ureidopropanamide based N-formyl peptide receptor 2 (FPR2) agonists with potential application for central nervous system disorders characterized by neuroinflammation. Eur J Med Chem 2017;141:703-20. [PMID: 29102463 DOI: 10.1016/j.ejmech.2017.09.023] [Cited by in Crossref: 27] [Cited by in F6Publishing: 26] [Article Influence: 4.5] [Reference Citation Analysis]
|
| 103 |
Saito Y, Nakamura K, Miura D, Yunoki K, Miyoshi T, Yoshida M, Kawakita N, Kimura T, Kondo M, Sarashina T, Akagi S, Watanabe A, Nishii N, Morita H, Ito H. Suppression of Wnt Signaling and Osteogenic Changes in Vascular Smooth Muscle Cells by Eicosapentaenoic Acid. Nutrients 2017;9:E858. [PMID: 28796175 DOI: 10.3390/nu9080858] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 104 |
Vik A, Dalli J, Hansen TV. Recent advances in the chemistry and biology of anti-inflammatory and specialized pro-resolving mediators biosynthesized from n-3 docosapentaenoic acid. Bioorg Med Chem Lett 2017;27:2259-66. [PMID: 28408222 DOI: 10.1016/j.bmcl.2017.03.079] [Cited by in Crossref: 45] [Cited by in F6Publishing: 47] [Article Influence: 7.5] [Reference Citation Analysis]
|
| 105 |
Proschak E, Heitel P, Kalinowsky L, Merk D. Opportunities and Challenges for Fatty Acid Mimetics in Drug Discovery. J Med Chem 2017;60:5235-66. [PMID: 28252961 DOI: 10.1021/acs.jmedchem.6b01287] [Cited by in Crossref: 56] [Cited by in F6Publishing: 56] [Article Influence: 9.3] [Reference Citation Analysis]
|
| 106 |
Jerschow E, Edin ML, Pelletier T, Abuzeid WM, Akbar NA, Gibber M, Fried M, Lih FB, Gruzdev A, Bradbury JA, Han W, Hudes G, Keskin T, Schuster VL, Spivack S, Zeldin DC, Rosenstreich D. Plasma 15-Hydroxyeicosatetraenoic Acid Predicts Treatment Outcomes in Aspirin-Exacerbated Respiratory Disease. J Allergy Clin Immunol Pract 2017;5:998-1007.e2. [PMID: 28159558 DOI: 10.1016/j.jaip.2016.11.021] [Cited by in Crossref: 25] [Cited by in F6Publishing: 26] [Article Influence: 4.2] [Reference Citation Analysis]
|
| 107 |
Codagnone M, Recchiuti A, Lanuti P, Pierdomenico AM, Cianci E, Patruno S, Mari VC, Simiele F, Di Tomo P, Pandolfi A, Romano M. Lipoxin A4 stimulates endothelial miR-126-5p expression and its transfer via microvesicles. FASEB J 2017;31:1856-66. [PMID: 28100645 DOI: 10.1096/fj.201600952R] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 3.5] [Reference Citation Analysis]
|
| 108 |
Tian Z, Pang H, Du S, Lu Y, Zhang L, Wu H, Guo S, Wang M, Zhang Q. Effect of Panax notoginseng saponins on the pharmacokinetics of aspirin in rats. Journal of Chromatography B 2017;1040:136-43. [DOI: 10.1016/j.jchromb.2016.12.007] [Cited by in Crossref: 29] [Cited by in F6Publishing: 29] [Article Influence: 4.8] [Reference Citation Analysis]
|
| 109 |
Wakabayashi M, Yoshioka T, Higashino K, Numata Y, Igarashi Y, Kihara A. Decreases in 15-lipoxygenase metabolites in Olmsted syndrome model rats. J Dermatol Sci 2017;85:186-96. [PMID: 28024685 DOI: 10.1016/j.jdermsci.2016.12.013] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 110 |
Nagaya T, Kawata K, Kamekura R, Jitsukawa S, Kubo T, Kamei M, Ogasawara N, Takano KI, Himi T, Ichimiya S. Lipid mediators foster the differentiation of T follicular helper cells. Immunol Lett 2017;181:51-7. [PMID: 27838468 DOI: 10.1016/j.imlet.2016.11.006] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 2.4] [Reference Citation Analysis]
|
| 111 |
Cianci E, Trubiani O, Diomede F, Merciaro I, Meschini I, Bruni P, Croce F, Romano M. Immobilization and delivery of biologically active Lipoxin A4 using electrospinning technology. Int J Pharm 2016;515:254-61. [PMID: 27732897 DOI: 10.1016/j.ijpharm.2016.09.077] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 112 |
Talevi A. Computational approaches for innovative antiepileptic drug discovery. Expert Opinion on Drug Discovery 2016;11:1001-16. [DOI: 10.1080/17460441.2016.1216965] [Cited by in Crossref: 10] [Cited by in F6Publishing: 5] [Article Influence: 1.4] [Reference Citation Analysis]
|
| 113 |
Schoergenhofer C, Schwameis M, Lagler H, Jilma B. Editorial on low-dose acetylsalicylic acid treatment and impact on short-term mortality in Staphylococcus aureus bloodstream infection: a propensity score-matched cohort study. Ann Transl Med 2016;4:199. [PMID: 27294095 DOI: 10.21037/atm.2016.05.35] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 114 |
Deeb RS, Hajjar DP. Repair Mechanisms in Oxidant-Driven Chronic Inflammatory Disease. Am J Pathol 2016;186:1736-49. [PMID: 27171899 DOI: 10.1016/j.ajpath.2016.03.001] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 115 |
Brigatte P, Faiad OJ, Ferreira Nocelli RC, Landgraf RG, Palma MS, Cury Y, Curi R, Sampaio SC. Walker 256 Tumor Growth Suppression by Crotoxin Involves Formyl Peptide Receptors and Lipoxin A₄. Mediators Inflamm 2016;2016:2457532. [PMID: 27190493 DOI: 10.1155/2016/2457532] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 2.4] [Reference Citation Analysis]
|
| 116 |
Börgeson E. The role of lipoxins in cardiometabolic physiology and disease. Cardiovascular Endocrinology 2016;5:4-13. [DOI: 10.1097/xce.0000000000000068] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 117 |
Lochhead PJ, Chan AT. Aspirin and the Prevention of Colorectal Cancer. NSAIDs and Aspirin 2016. [DOI: 10.1007/978-3-319-33889-7_14] [Reference Citation Analysis]
|
| 118 |
Basil MC, Levy BD. Specialized pro-resolving mediators: endogenous regulators of infection and inflammation. Nat Rev Immunol 2016;16:51-67. [PMID: 26688348 DOI: 10.1038/nri.2015.4] [Cited by in Crossref: 337] [Cited by in F6Publishing: 348] [Article Influence: 42.1] [Reference Citation Analysis]
|
